293 related articles for article (PubMed ID: 33205157)
1. The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits.
Lüll K; Arffman RK; Sola-Leyva A; Molina NM; Aasmets O; Herzig KH; Plaza-Díaz J; Franks S; Morin-Papunen L; Tapanainen JS; Salumets A; Altmäe S; Piltonen TT; Org E
J Clin Endocrinol Metab; 2021 Mar; 106(3):858-871. PubMed ID: 33205157
[TBL] [Abstract][Full Text] [Related]
2. Gut bacteriome and mood disorders in women with PCOS.
Lee S; Tejesvi MV; Hurskainen E; Aasmets O; Plaza-Díaz J; Franks S; Morin-Papunen L; Tapanainen JS; Ruuska TS; Altmäe S; Org E; Salumets A; Arffman RK; Piltonen TT
Hum Reprod; 2024 Jun; 39(6):1291-1302. PubMed ID: 38614956
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
[TBL] [Abstract][Full Text] [Related]
4. Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota.
Jobira B; Frank DN; Pyle L; Silveira LJ; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2134-44. PubMed ID: 31970418
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
6. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
He F; Li Y
J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report.
Liang Y; Ming Q; Liang J; Zhang Y; Zhang H; Shen T
Can J Physiol Pharmacol; 2020 Nov; 98(11):803-809. PubMed ID: 32150694
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
Eyupoglu ND; Ergunay K; Acikgoz A; Akyon Y; Yilmaz E; Yildiz BO
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32860695
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
11. Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.
Zheng Y; Yu J; Liang C; Li S; Wen X; Li Y
Bioprocess Biosyst Eng; 2021 May; 44(5):953-964. PubMed ID: 32157446
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity.
Insenser M; Murri M; Del Campo R; Martínez-García MÁ; Fernández-Durán E; Escobar-Morreale HF
J Clin Endocrinol Metab; 2018 Jul; 103(7):2552-2562. PubMed ID: 29897462
[TBL] [Abstract][Full Text] [Related]
14. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.
Tayachew B; Vanden Brink H; Garcia-Reyes Y; Rahat H; D'Alessandro A; Frank DN; Robertson CE; Silveira L; Kelsey M; Pyle L; Cree-Green M
Front Physiol; 2022; 13():887077. PubMed ID: 35800349
[No Abstract] [Full Text] [Related]
15. The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome.
Kelley ST; Skarra DV; Rivera AJ; Thackray VG
PLoS One; 2016; 11(1):e0146509. PubMed ID: 26731268
[TBL] [Abstract][Full Text] [Related]
16. Blood Bacterial 16S rRNA Gene Alterations in Women With Polycystic Ovary Syndrome.
Wang Q; Wang Q; Zhao L; Bin Y; Wang L; Wang L; Zhang K; Li Q
Front Endocrinol (Lausanne); 2022; 13():814520. PubMed ID: 35282443
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
18. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
19. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Li P; Shuai P; Shen S; Zheng H; Sun P; Zhang R; Lan S; Lan Z; Jayawardana T; Yang Y; Zhao J; Liu Y; Chen X; El-Omar EM; Wan Z
BMC Med; 2023 Aug; 21(1):302. PubMed ID: 37559119
[TBL] [Abstract][Full Text] [Related]
20. Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics.
Haudum C; Lindheim L; Ascani A; Trummer C; Horvath A; Münzker J; Obermayer-Pietsch B
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32492805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
